Danny Kinahan – 2015 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Danny Kinahan on 2015-11-30.

To ask the Secretary of State for Health, what assessment he has made of the reasons for removing treatment options for (a) multiple myeloma and (b) other rare cancers from the Cancer Drugs Fund.

George Freeman

No such assessment has been made. NHS England is responsible for the operational management of the Cancer Drugs Fund (CDF) and decisions on which treatments are included on the national CDF list are made by the CDF expert clinical panel, which includes expert oncologists, oncology pharmacists and patient representatives.